BRIEF published on 11/27/2025 at 00:20, 1 month 14 days ago Transgene: Resumption of Trading on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/27/2025 at 00:15, 1 month 14 days ago Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets Transgene resumes trading of shares on Euronext Paris following capital increase results publication Euronext Paris Shares Trading Capital Increase Transgene
BRIEF published on 11/26/2025 at 23:37, 1 month 14 days ago Transgene Raises €105 Million for Cancer Vaccine Development Biotechnology Fundraising Cancer Vaccines Transgene Myvac® Platform
PRESS RELEASE published on 11/26/2025 at 23:32, 1 month 14 days ago Transgene Successfully Completes a Fundraising of c. €105 Million Transgene successfully completes a fundraising of c. €105 million, enabling acceleration of myvac® program development and extending financial visibility until early 2028 Fundraising Cancer Vaccines Transgene Financial Visibility Myvac® Program
BRIEF published on 11/25/2025 at 22:06, 1 month 16 days ago Transgene raises funds with the Talisman project Euronext Paris Fundraising Transgene Talisman Myvac®
BRIEF published on 11/25/2025 at 21:47, 1 month 16 days ago Temporary suspension of trading in Transgene shares Euronext Paris Biotechnology Capital Increase Transgene Quoting
PRESS RELEASE published on 11/25/2025 at 21:42, 1 month 16 days ago Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results. Trading to resume on November 27, 2025 Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 20:46, 1 month 16 days ago Temporary Suspension of Trading in Transgene Shares on Euronext Paris Euronext Paris Biotechnology Capital Increase Transgene Trading Suspended
PRESS RELEASE published on 11/25/2025 at 20:41, 1 month 16 days ago Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris Transgene requests temporary suspension of trading on Euronext Paris pending capital increase results Euronext Paris Trading Capital Increase Suspension Transgene
BRIEF published on 11/25/2025 at 19:20, 1 month 16 days ago Transgene Launches €105 Million Fundraising Initiative Biotechnology Investment Transgene Fundraising Myvac® Program Cancer Vaccine Development Institutional And Retail Offerings
Published on 01/10/2026 at 05:10, 1 day 18 hours ago Sekur Private Data Ltd. Announces Non-Brokered Private Placement
Published on 01/10/2026 at 00:45, 1 day 22 hours ago Digi Power X Announces Entry into Settlement Agreement
Published on 01/09/2026 at 23:30, 2 days ago Matador Technologies Announces Grant of Restricted Share Units to Management Team
Published on 01/09/2026 at 23:10, 2 days ago Usha Resources and Totec Resources Provide Supplemental Disclosure for Qualifying Transaction
Published on 01/11/2026 at 22:20, 1 hour 12 minutes ago Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Published on 01/10/2026 at 21:25, 1 day 2 hours ago CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
Published on 01/10/2026 at 13:05, 1 day 10 hours ago SeaVerse Launches World's First AI Native Platform, "All in AI Native" Leads the Forward-Looking Revolution in AI Creation
Published on 01/09/2026 at 21:55, 2 days 1 hour ago Piramal Pharma Achieves Notable Score Increase on 2025 S&P Global Corporate Sustainability Assessment (CSA)
Published on 01/09/2026 at 18:36, 2 days 4 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/09/2026 at 18:30, 2 days 5 hours ago H2 2025 half yearly report on the liquidity agreement signed with the Gilbert Dupont brokerage firm
Published on 01/09/2026 at 17:45, 2 days 5 hours ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 01/09/2026 at 17:42, 2 days 5 hours ago Aéroports de Paris SA - Shares and voting rights as of 31 December 2025
Published on 01/08/2026 at 21:00, 3 days 2 hours ago Biannual report on SEB S.A.’S liquidity agreement
